Brown JR. Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”. Haematologica 2022;107(6):1491-1492; https://doi.org/10.3324/haematol.2021.280310.